Evidence map›Paper›PMID 38006383›Full record

ArticleClinical and translational allergy2023

Human bocavirus 1 coinfection is associated with decreased cytokine expression in the rhinovirus-induced first wheezing episode in children.

Pekka Hurme, Reetta Sahla, Beate Rückert, Tero Vahlberg, Riitta Turunen, Tytti Vuorinen, Mübeccel Akdis, Maria Söderlund-Venermo, Cezmi Akdis, Tuomas Jartti

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational allergy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2025
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Pekka HurmeDepartment of Pediatrics and Adolescent Medicine, Turku University Hospital, University of Turku, Turku, Finland.ORCID https://orcid.org/0000-0002-9748-2442
Reetta SahlaDepartment of Pediatrics and Adolescent Medicine, Turku University Hospital, University of Turku, Turku, Finland.
Beate RückertSwiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Tero VahlbergDepartment of Biostatistics, University of Turku, Turku, Finland.
Riitta TurunenDepartment of Pediatrics and Adolescent Medicine, Turku University Hospital, University of Turku, Turku, Finland.
Tytti VuorinenInstitute of Biomedicine, University of Turku, Turku, Finland.
Mübeccel AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Maria Söderlund-VenermoDepartment of Virology, University of Helsinki, Helsinki, Finland.
Cezmi AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Tuomas JarttiDepartment of Pediatrics and Adolescent Medicine, Turku University Hospital, University of Turku, Turku, Finland.
University of Turku · FICK-CARE · CHUniversity of Helsinki · FI

Funding

Academy of Finland 114034Academy of Finland 132595AllergiasäätiöJalmari ja Rauha Ahokkaan SäätiöLastentautien TutkimussäätiöPaulon SäätiöSigrid Juséliuksen SäätiöSuomen KulttuurirahastoSuomen Lääketieteen SäätiöThe Life and Health Medical Support Association, Helsinki, FinlandTurun Yliopistosäätiö
6 · The paper itself

Abstract

backgroundRhinovirus (RV)-induced first wheezing episodes in children are associated with a markedly increased risk of asthma. Previous studies have suggested that human bocavirus 1 (HBoV1) may modify RV-induced immune responses in young children. We investigated cytokine profiles of sole RV- and dual RV-HBoV1-induced first wheezing episodes, and their association with severity and prognosis.

methodsFifty-two children infected with only RV and nine children infected with dual RV-HBoV1, aged 3-23 months, with severe first wheezing episodes were recruited. At acute illness and 2 weeks later, peripheral blood mononuclear cells were isolated, and stimulated with anti-CD3/anti-CD28 in vitro. Multiplex ELISA was used to quantitatively identify 56 different cytokines at both study points. Patients were prospectively followed for 4 years.

resultsThe mean age of the children was 14.3 months, and 30% were sensitized. During the acute illness, the adjusted analyses revealed a decrease in the expression of IL-1b, MIP-1b, Regulated upon activation, normal T cell expressed and presumably secreted (CCL5), TNF-a, TARC, and ENA-78 in the RV-HBoV1 group compared with the RV group. In the convalescence phase, the RV-HBoV1 group was characterized by decreased expression of Fractalkine, MCP-3, and IL-8 compared to the RV group. Furthermore, the hospitalization time was associated with the virus group and cytokine response (interaction p < 0.05), signifying that increased levels of epidermal growth factor and MIP-1b were related with a shorter duration of hospitalization in the RV-HBoV1 coinfection group but not in the RV group.

conclusionsDifferent cytokine response profiles were detected between the RV and the RV-HBoV1 groups. Our results show the idea that RV-induced immune responses may be suppressed by HBoV1.

Indexed as

bocavirusbronchiolitiscytokinerhinovirusviruswheezewheezing

Identifiers

PMID38006383
PMCPMC10642552
OpenAlexW4388651957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.